Jones M H, Koi S, Fujimoto I, Hasumi K, Kato K, Nakamura Y
Department of Biochemistry, Cancer Institute, Tokyo, Japan.
Genes Chromosomes Cancer. 1994 Feb;9(2):119-23. doi: 10.1002/gcc.2870090207.
Cancers in which mutations have been identified in putative tumor suppressor genes, such as the TP53 gene, the retinoblastoma (RBI) gene, the adenomatous polyposis coli (APC) gene, and the Wilms tumor (WTI) gene, frequently show loss of the corresponding allele on the homologous chromosome. To identify locations of tumor suppressor genes involved in uterine cancer, we examined loss of heterozygosity (LOH) by using genomic probes detecting RFLPs in 35 uterine cancers at 29 loci throughout the genome, and with highly informative microsatellite markers in 21 uterine cancers at nine putative or known tumor suppressor gene loci. High frequencies of allelic loss found at loci on 3p (71%), 9q (38%), 10q (35%), and 17p (35%) suggest that tumor suppressor genes involved in uterine carcinogenesis exist in these regions. There were no significant differences in frequencies of LOH between cancers of the uterine cervix and cancers of the uterine endometrium at any of the loci tested.
在诸如TP53基因、视网膜母细胞瘤(RBI)基因、腺瘤性息肉病 coli(APC)基因和威尔姆斯瘤(WTI)基因等推定的肿瘤抑制基因中已鉴定出突变的癌症,常常显示同源染色体上相应等位基因的缺失。为了确定参与子宫癌的肿瘤抑制基因的位置,我们通过使用检测全基因组29个位点的RFLP的基因组探针,以及在9个推定或已知的肿瘤抑制基因位点使用信息丰富的微卫星标记,对21例子宫癌检测杂合性缺失(LOH)。在3p(71%)、9q(38%)、10q(35%)和17p(35%)位点发现的高频率等位基因缺失表明,参与子宫癌发生的肿瘤抑制基因存在于这些区域。在任何测试位点,子宫颈癌和子宫内膜癌的LOH频率均无显著差异。